Salt and its effect on blood pressure and target organ damage: New pieces in an old puzzle

Journal of Nephrology

Volumn 22, Issue 2, 2009, Pages 177-189

  Titze, Jens ^a   Ritz, Eberhard ^b,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Nierenzentrum   (Germany)

Author keywords

Cardiotonic steroids; CKD; Dialysis; Disease; Hypertension; Salt

Indexed keywords

SODIUM CHLORIDE;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK REDUCTION; SALT INTAKE; SODIUM RESTRICTION; SODIUM RETENTION; TARGET ORGAN; BLOOD PRESSURE; DRUG EFFECT; METHODOLOGY; PROGNOSIS; SODIUM INTAKE;

BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; HUMANS; HYPERTENSION; PROGNOSIS; SODIUM, DIETARY;

EID: 67649399411     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Alderman MH. Evidence relating dietary sodium to cardiovascular disease. J Am Coll Nutr. 2006; 25 (Suppl 3): S256-S261.
2. MacGregor GA, de Wardener HE. Salt, diet and health: Neptune's poisoned chalice; the origins of high blood pressure. New York: Cambridge University Press; 1998.
3. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297:319-328.
4. Tuomilehto J, Jousilahti P, Rastenyte D, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001;357:848-851.
5. Schreuder MF, Bokenkamp A, van Wijk JA. Salt intake in children: increasing concerns? Hypertension. 2007;49:e10.
6. Alderman MH. Salt and blood pressure in children. J Hum Hypertens. 2008;22:1-3.
7. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2004;CD004937.
8. Hooper L, Bartlett C, Davey SG, Ebrahim S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev. 2004;CD003656.
9. Jurgens G, Graudal NA. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database Syst Rev. 2004;CD004022.
10. Al-Awqati Q. Evidence-based politics of salt and blood pressure. Kidney Int. 2006;69:1707-1708.
11. Hanneman RL. On Kidney International editorial: evidence-based politics of salt and blood pressure? Kidney Int. 2007;71:85.
12. Beard TC, Stowasser M. Cochrane and the salt debate. Lancet. 2003;362:403 [discussion: 403].
13. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10.
14. He FJ, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension. 2000;35:544-549.
15. Hunt SC, Cook NR, Oberman A, et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension. 1998;32:393-401.
16. Denton D, Weisinger R, Mundy NI, et al. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995;1:1009-1016.
17. Elliott P, Walker LL, Little MP, et al. Change in salt intake affects blood pressure of chimpanzees: implications for human populations. Circulation. 2007;116:1563-1568.
18. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334:885.
19. He FJ, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999;282:2027-2034.
20. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension. 2003;42:1093-1099.
21. Melander O, von Wowern F, Frandsen E, et al. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. J Hypertens. 2007;25:619-627.
22. Sanders PW. Effect of salt intake on progression of chronic kidney disease. Curr Opin Nephrol Hypertens. 2006;15:54-60.
23. Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007;356:1966-1978.
24. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
25. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296-308.
26. Rust MB, Faulhaber J, Budack MK, et al. Neurogenic mechanisms contribute to hypertension in mice with disruption of the K-Cl cotransporter KCC3. Circ Res. 2006;98:549-556.
27. Bergier J-F. Une histoire du sel. Fribourg (Switzerland): Office du libre; 1982.
28. Kurlansky M. Salt: a world history: London: Random House, Vintage; 2003.
29. Hocquet J.-C.. Le sel et le pouvoir Paris: Albin Michel; 1985.
30. Ambard L, Beaujard BE. Causes de l'hypertension artérielle. Arch Gén Med. 1904;1:520-533.
31. Volhard F and Fahr T. Die Brightsche Nierenkrankheit. Berlin: Julius Springer; 1914.
32. Fishberg AM. Hypertension and Nephritis. Philadelphia: Lea and Febiger; 1939.
33. Kempner W. Treatment of hypertensive vascular disease with rice diet. Arch Intern Med. 1974;133:758-790.
34. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
35. Whelton PK, He FJ, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882-1888.
36. Sowers JR. Hypertension, angiotensin II, and oxidative stress. N Engl J Med. 2002;346:1999-2001.
37. Denton D. The hunger for salt. Berlin, Heidelberg, New York, Tokyo: Springer Verlag; 1984.
38. Ritz E. The history of salt: aspects of interest to the nephrologist. Nephrol Dial Transplant. 1996;11:969-975.
39. Cohen HW, Alderman MH. Sodium, blood pressure, and cardiovascular disease. Curr Opin Cardiol. 2007;22:306-310.
40. Weinberger MH. Pathogenesis of salt sensitivity of blood pressure. Curr Hypertens Rep. 2006;8:166-170.
41. Cianciaruso B, Bellizzi V, Minutolo R, et al. Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol. 1996;7:306-313.
42. Weir MR, Fink JC. Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. Am J Kidney Dis. 2005;45:176-188.
43. Anderson DE, Fedorova OV, Morrell CH, et al. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1248-R1254.
44. Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol. 2007;27:44-54.
45. Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ. 1996;312:1249-1253.
46. Stamler J. The INTERSALT study: background, methods, findings, and implications. Am J Clin Nutr. 1997;65(2 Suppl):626S-642S.
47. Davey Smith G, Phillips AN. Intersalt data. Correction for regression dilution bias in Intersalt study was misleading. BMJ. 1997;315:485-486 [author reply: 487].
48. Forte JG, Miguel JM, Miguel MJ, de Padua F, Rose G. Salt and blood pressure: a community trial. J Hum Hypertens. 1989;3:179-184.
49. Geleijnse JM, Hofman A, Witteman JC, Hazebroek AA, Valkenburg HA, Grobbee DE. Long-term effects of neonatal sodium restriction on blood pressure. Hypertension. 1997;29:913-917.
50. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997;315:722-729.
51. Smith WC, Crombie IK, Tavendale RT, Gulland SK, Tunstall-Pedoe HD. Urinary electrolyte excretion, alcohol consumption, and blood pressure in the Scottish heart health study. BMJ. 1988;297:329-330.
52. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years: focus on lifestyle and salt intake. Circulation. 1994;89:1041-1050.
53. Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II follow-up study. Am J Med. 2006;119:e277-275.
54. Leiba A, Vald A, Peleg E, Shamiss A, Grossman E. Does dietary recall adequately assess sodium, potassium, and calcium intake in hypertensive patients? Nutrition. 2005;21:462-466.
55. Geleijnse JM, Witteman JC, Stijnen T, Kloos MW, Hofman A, Grobbee DE. Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: the Rotterdam Study. Eur J Epidemiol. 2007;22:763-770.
56. Franco V, Oparil S. Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr. 2006;25(3 Suppl):247S-255S.
57. Frohlich ED. The salt conundrum: a hypothesis. Hypertension. 2007;50:161-166.
58. Dworkin LD, Benstein JA, Tolbert E, Feiner HD. Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease. J Am Soc Nephrol. 1996;7:437-442.
59. Nagashima A, Okuda S, Tamaki K, Fujishima M. Influence of a high salt diet on glomerular injury and the preventive effects of amiloride in Adriamycin nephropathy. Nephron. 1995;71:87-94.
60. Kitiyakara C, Chabrashvili T, Chen Y, et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol. 2003;14:2775-2782.
61. Kreutz R, Kovacevic L, Schulz A, Rothermund L, Ketteler M, Paul M. Effect of high NaCl diet on spontaneous hypertension in a genetic rat model with reduced nephron number. J Hypertens. 2000;18:777-782.
62. Sanders MW, Fazzi GE, Janssen GM, Blanco CE, De Mey JG. High sodium intake increases blood pressure and alters renal function in intrauterine growth-retarded rats. Hypertension. 2005;46:71-75.
63. Woods LL, Weeks DA, Rasch R. Hypertension after neonatal uninephrectomy in rats precedes glomerular damage. Hypertension. 2001;38:337-342.
64. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348:101-108.
65. Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE. Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int. 2006;69:671-678.
66. Yu HC, Burrell LM, Black MJ, et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation. 1998;98:2621-2628.
67. Sanders PW, Gibbs CL, Akhi KM, et al. Increased dietary salt accelerates chronic allograft nephropathy in rats. Kidney Int. 2001;59:1149-1157.
68. Verhave JC, Hillege HL, Burgerhof JG, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med. 2004;256:324-330.
69. Krikken JA, Lely AT, Bakker SJ, Navis G. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int. 2007;71:260-265.
70. Cianciaruso B, Bellizzi V, Minutolo R, et al. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab. 1998;24:296-301.
71. Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM. The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. 1960. J Am Soc Nephrol. 1998;9:719-726 [discussion: 719-726].
72. Comty C, Rottka H, Shaldon S. Blood pressure control in patients with end-stage renal failure treated by intermittent hemodialysis. Paper presented at the proceedings of the European Dialysis and Transplant Association, Amsterdam sept 1964.
73. Charra B, Calemard E, Ruffet M, et al. Survival as an index of adequacy of dialysis. Kidney Int. 1992;41:1286-1291.
74. Ozkahya M, Ok E, Toz H, et al. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant. 2006;21:3506-3513.
75. Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant. 1998;13:552-553.
76. Ozkahya M, Ok E, Cirit M, et al. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant. 1998;13:1489-1493.
77. Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353:1838-1842.
78. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol. 2007;293:C509-C536.
79. Kennedy DJ, Vetteth S, Periyasamy SM, et al. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension. 2006;47:488-495.
80. Stella P, Manunta P, Mallamaci F, et al. Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med. 2008;263:274-280.
81. Ritz E, Dikow R, Morath C, Schwenger V. Salt: a potential 'uremic toxin'? Blood Purif. 2006;24:63-66.
82. Heer M. Reply to the letter to the editor by Louise Weschler entitled 'Under what conditions is ingested sodium rendered osmotically inactive'? Am J Physiol Regul Integr Comp Physiol. 2006 Apr 27.
83. Titze J, Maillet A, Lang R, et al. Long-term sodium balance in humans in a terrestrial space station simulation study. Am J Kidney Dis. 2002;40:508-516.
84. Titze J, Bauer K, Schafflhuber M, et al. Internal sodium balance in DOCA-salt rats: a body composition study. Am J Physiol Renal Physiol. 2005;289:F793-F802.
85. Titze J, Luft FC, Bauer K, et al. Extrarenal Na+ balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorticosterone-acetate salt rats. Hypertension. 2006;47:1101-1107.
86. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A. 2007;104:16281-16286.
87. Withering W. An account of the foxglove and some of its medical uses (with practical remarks on dropsy and other diseases). Birmingham; 1785.
88. Aperia A. New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target. J Intern Med. 2007;261:44-52.
89. de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004;66:2454-2466.
90. Lichtstein D, Rosen H. Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function. Neurochem Res. 2001;26:971-978.
91. Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs. Cardiovasc Res. 1996;31:296-305.
92. Lopatin DA, Ailamazian EK, Dmitrieva RI, et al. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens. 1999;17:1179-1187.
93. Fedorova OV, Lakatta EG, Bagrov AY. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats. Circulation. 2000;102:3009-3014.
94. Gonick HC, Ding Y, Vaziri ND, Bagrov AY, Fedorova OV. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clin Exp Hypertens. 1998;20:617-627.
95. Ferrari P, Ferrandi M, Tripodi G, et al. PST 2238: a new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. J Pharmacol Exp Ther. 1999;288:1074-1083.
96. Vu H, Ianosi-Irimie M, Danchuk S, et al. Resibufogenin corrects hypertension in a rat model of human preeclampsia. Exp Biol Med (Maywood). 2006;231:215-220.
97. Schafflhuber M, Volpi N, Dahlmann A, et al. Mobilization of osmotically inactive Na+ by growth and by dietary salt restriction in rats. Am J Physiol Renal Physiol. 2007;292:F1490-F1500.
98. Titze J, Lang R, Ilies C, et al. Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol. 2003;285:F1108-F1117.
99. Titze J, Shakibaei M, Schafflhuber M, et al. Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. Am J Physiol Heart Circ Physiol. 2004;287:H203-H208.
100. Strauss MB, Lamdin E, Smith WP, Bleifer DJ. Surfeit and deficit of sodium: a kinetic concept of sodium excretion. AMA Arch Intern Med. 1958;102:527-536.
101. Baker NA, Sept B, Joseph S, Holst MJ, McCammon JA. Electrostatis of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci. 2001;98:10037-10041.
102. Jones LS, Yazzie B, Middaugh CR. Polyanions and the proteome. Mol Cell Proteomics. 2004;3:746-769.
103. Pitts RF. Volume and composition of the body fluids. Chicago, IL: Year Book; 1974.
104. Ziomber A, Machnik A, Dahlmann A, et al. Sodium-, potassium-, chloride-, and bicarbonate-related effects on blood pressure and electrolyte homeostasis in deoxycorticosterone acetate-treated rats. Am J Physiol Renal Physiol. 2008;295:F1752-F1763.
105. Rossier BC, Schild L. Epithelial sodium channel: mendelian versus essential hypertension. Hypertension. 2008;52:595-600.
106. Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension. 2001;37:1458-1464.
107. Fava C, Montagnana M, Rosberg L, et al. Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum Mol Genet. 2008;17:413-418.
108. Fava C, von Wowern F, Berglund G, et al. 24-h ambulatory blood pressure is linked to chromosome 18q21-22 and genetic variation of NEDD4L associates with cross-sectional and longitudinal blood pressure in Swedes. Kidney Int. 2006;70:562-569.
109. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
110. Benstein JA, Feiner HD, Parker M, Dworkin LD. Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol. 1990;258(6 Pt 2):F1675-F1681.
111. Sanchez-Castillo CP, Warrender S, Whitehead TP, James WP. An assessment of the sources of dietary salt in a British population. Clin Sci (Lond). 1987;72:95-102.
112. Kastarinen M, Laatikainen T, Salomaa V, et al. Trends in lifestyle factors affecting blood pressure in hypertensive and normotensive Finns during 1982-2002. J Hypertens. 2007;25:299-305.